Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Safety and Efficacy of Concomitant Erenumab and INP104 Use From the Phase 3 STOP 301 Study in Migraine Patients

Safety of Concomitant Triptan and INP104 Use From the Phase 3 STOP 301 Study in Migraine Patients

The Analysis of 607 Volunteers Shows a Reduction of Workability in Individuals With LONG-COVID Syndrome Associated With Neuropsychiatric Symptoms